首页> 美国卫生研究院文献>Nutrition Reviews >Possible association between celiac disease and bacterial transglutaminase in food processing: a hypothesis
【2h】

Possible association between celiac disease and bacterial transglutaminase in food processing: a hypothesis

机译:乳糜泻和细菌转谷氨酰胺酶在食品加工中的可能关联:一种假设

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The incidence of celiac disease is increasing worldwide, and human tissue transglutaminase has long been considered the autoantigen of celiac disease. Concomitantly, the food industry has introduced ingredients such as microbial transglutaminase, which acts as a food glue, thereby revolutionizing food qualities. Several observations have led to the hypothesis that microbial transglutaminase is a new environmental enhancer of celiac disease. First, microbial transglutaminase deamidates/transamidates glutens such as the endogenous human tissue transglutaminase. It is capable of crosslinking proteins and other macromolecules, thereby changing their antigenicity and resulting in an increased antigenic load presented to the immune system. Second, it increases the stability of protein against proteinases, thus diminishing foreign protein elimination. Infections and the crosslinked nutritional constituent gluten and microbial transglutaminase increase the permeability of the intestine, where microbial transglutaminases are necessary for bacterial survival. The resulting intestinal leakage allows more immunogenic foreign molecules to induce celiac disease. The increased use of microbial transglutaminase in food processing may promote celiac pathogenesis ex vivo, where deamidation/transamidation starts, possibly explaining the surge in incidence of celiac disease. If future research substantiates this hypothesis, the findings will affect food product labeling, food additive policies of the food industry, and consumer health education.
机译:乳糜泻的发病率在全世界范围内都在增加,并且人类组织转谷氨酰胺酶长期以来一直被认为是乳糜泻的自身抗原。随之而来的是,食品工业引入了诸如微生物转谷氨酰胺酶等成分,该成分可充当食品胶,从而彻底改变了食品质量。几种观察结果提出了这样的假设,即微生物转谷氨酰胺酶是一种新型的腹腔疾病环境增强剂。首先,微生物转谷氨酰胺脱酰胺/转谷蛋白,例如内源性人类组织转谷氨酰胺。它能够使蛋白质和其他大分子交联,从而改变它们的抗原性并导致增加免疫系统的抗原负荷。其次,它增加了蛋白质抵抗蛋白酶的稳定性,从而减少了外来蛋白质的消除。感染和交联的营养成分面筋和微生物转谷氨酰胺酶可增加肠道的通透性,而微生物转谷氨酰胺酶对于细菌的生存是必不可少的。导致的肠道泄漏使更多的免疫原性外源分子诱发乳糜泻。微生物转谷氨酰胺酶在食品加工中的使用增加可能促进离体腹腔疾病的发生,脱酰胺/转酰胺作用开始于体外,这可能解释了腹腔疾病发病率的上升。如果未来的研究证实这一假设,那么这些发现将影响食品标签,食品行业的食品添加剂政策以及消费者健康教育。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号